BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18758069)

  • 1. Mouse-human chimeric anti-Tn IgG1 induced anti-tumor activity against Jurkat cells in vitro and in vivo.
    Ando H; Matsushita T; Wakitani M; Sato T; Kodama-Nishida S; Shibata K; Shitara K; Ohta S
    Biol Pharm Bull; 2008 Sep; 31(9):1739-44. PubMed ID: 18758069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti-tumor activity.
    Welinder C; Baldetorp B; Borrebaeck C; Fredlund BM; Jansson B
    Glycobiology; 2011 Aug; 21(8):1097-107. PubMed ID: 21470982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells.
    Blixt O; Lavrova OI; Mazurov DV; Cló E; Kracun SK; Bovin NV; Filatov AV
    Glycobiology; 2012 Apr; 22(4):529-42. PubMed ID: 22143985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and functional characterization of two mouse/human chimeric antibodies with specificity for the tumor-associated Tn-antigen.
    Oppezzo P; Osinaga E; Tello D; Bay S; Cantacuzene D; Irigoín F; Ferreira A; Roseto A; Cayota A; Alzari P; Pritsch O
    Hybridoma; 2000 Jun; 19(3):229-39. PubMed ID: 10952411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
    Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
    Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface plasmon resonance and NMR analyses of anti Tn-antigen MLS128 monoclonal antibody binding to two or three consecutive Tn-antigen clusters.
    Matsumoto-Takasaki A; Hanashima S; Aoki A; Yuasa N; Ogawa H; Sato R; Kawakami H; Mizuno M; Nakada H; Yamaguchi Y; Fujita-Yamaguchi Y
    J Biochem; 2012 Mar; 151(3):273-82. PubMed ID: 22161472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of O-glycosylation-defective human lymphoid cell lines and flow cytometry to delineate the specificity of Moluccella laevis lectin and monoclonal antibody 5F4 for the Tn antigen (GalNAc alpha 1-O-Ser/Thr).
    Thurnher M; Clausen H; Sharon N; Berger EG
    Immunol Lett; 1993 Jun; 36(3):239-43. PubMed ID: 8370596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
    Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
    Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy.
    Hubert P; Heitzmann A; Viel S; Nicolas A; Sastre-Garau X; Oppezzo P; Pritsch O; Osinaga E; Amigorena S
    Cancer Res; 2011 Aug; 71(15):5134-43. PubMed ID: 21697279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
    Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
    MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel anti-human HB-EGF monoclonal antibody with multiple antitumor mechanisms against ovarian cancer cells.
    Miyamoto S; Iwamoto R; Furuya A; Takahashi K; Sasaki Y; Ando H; Yotsumoto F; Yoneda T; Hamaoka M; Yagi H; Murakami T; Hori S; Shitara K; Mekada E
    Clin Cancer Res; 2011 Nov; 17(21):6733-41. PubMed ID: 21918176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma.
    Niwa R; Shoji-Hosaka E; Sakurada M; Shinkawa T; Uchida K; Nakamura K; Matsushima K; Ueda R; Hanai N; Shitara K
    Cancer Res; 2004 Mar; 64(6):2127-33. PubMed ID: 15026353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel anti-Tn single-chain Fv-Fc fusion proteins derived from immunized phage library and antibody Fc domain.
    Kubota T; Matsushita T; Niwa R; Kumagai I; Nakamura K
    Anticancer Res; 2010 Sep; 30(9):3397-405. PubMed ID: 20944114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purified human anti-Tn and anti-T antibodies specifically recognize carcinoma tissues.
    Zlocowski N; Grupe V; Garay YC; Nores GA; Lardone RD; Irazoqui FJ
    Sci Rep; 2019 May; 9(1):8097. PubMed ID: 31147593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin G3 monoclonal antibody directed to Tn antigen (tumor-associated alpha-N-acetylgalactosaminyl epitope) that does not cross-react with blood group A antigen.
    Takahashi HK; Metoki R; Hakomori S
    Cancer Res; 1988 Aug; 48(15):4361-7. PubMed ID: 3390832
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.